Kurabo Industries (3106) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
10 Mar, 2026Executive summary
Net sales for the six months ended September 30, 2025, were ¥69.2 billion, down 3.6% year-over-year, with operating profit at ¥3.92 billion (down 7.3% YoY) and ordinary profit at ¥4.84 billion (down 5.0% YoY). Profit attributable to owners of parent rose 87.5% YoY to ¥6.42 billion, driven by extraordinary income from the sale of cross-shareholdings.
The company continued to focus on expanding high-profit businesses in semiconductors and life sciences, while restructuring its textiles business.
Financial highlights
Basic earnings per share for the period was ¥384.12, up from ¥193.12 in the prior year.
Comprehensive income reached ¥9.45 billion, up 91.6% YoY.
Total assets stood at ¥190.1 billion, with net assets at ¥125.7 billion and an equity-to-asset ratio of 65.4%.
Cash and cash equivalents at period-end were ¥14.98 billion, a decrease of ¥0.18 billion from the previous year.
Net cash provided by operating activities was ¥9.03 billion, while net cash used in investing and financing activities was ¥0.35 billion and ¥8.73 billion, respectively.
Outlook and guidance
Full-year net sales forecast remains at ¥144.0 billion (down 4.4% YoY), with operating profit at ¥8.0 billion and ordinary profit at ¥9.5 billion.
Profit attributable to owners of parent is revised upward to ¥10.5 billion (up 16.5% YoY), reflecting higher gains on sale of investment securities.
Segment forecasts: Chemical Products and Textiles are expected to see lower revenue and profit, while Advanced Technology is projected to grow.
Annual dividend forecast is ¥282 per share.
Latest events from Kurabo Industries
- Q1 profit more than doubled year-over-year, with upwardly revised full-year guidance.3106
Q1 202510 Mar 2026 - Operating and net profits surged despite lower revenue, with dividend and buyback plans announced.3106
Q2 202510 Mar 2026 - Net income surged 36.8% year-over-year on higher margins, despite a 1.0% revenue decline.3106
Q3 202510 Mar 2026 - Operating profit rose 12.3% YoY, but FY2026 outlook signals lower sales and earnings.3106
Q4 202510 Mar 2026 - Net income surged on extraordinary gains, but segment results and legal risks warrant caution.3106
Q1 202610 Mar 2026 - Profit rose sharply on asset sales despite lower sales, with segment results mixed.3106
Q3 202610 Mar 2026